{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:12:30Z","timestamp":1773789150782,"version":"3.50.1"},"reference-count":27,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>PALB2 (partner and localizer of BRCA2), as indicated by its name, is a BRCA2-interacting protein that plays an important role in homologous recombination (HR) and DNA double-strand break (DSB) repair. While pathogenic variants of PALB2 have been well proven to confer an increased risk of breast cancer, data on its involvement in prostate cancer (PrC) have not been clearly demonstrated. We investigated, using targeted next generation sequencing (NGS), a 59-year-old Caucasian man who developed synchronous breast and prostate cancers. This genetic investigation allowed to identify an intragenic germline heterozygous duplication in PALB2, implicating intronic repetitive sequences spanning exon 11. This variant was confirmed by multiplex ligation probe amplification (MLPA), and genomic breakpoints have been identified and characterized at the nucleotide level (c.3114-811_3202-1756dup) using an approach based on walking PCR, long range PCR, and Sanger sequencing. RT-PCR using mRNA extracted from lymphocytes and followed by Sanger sequencing revealed a tandem duplication r.3114_3201dup; p.(Gly1068Glufs * 14). This duplication results in the synthesis of a truncated, and most-likely, non-functional protein. These findings expand the phenotypic spectrum of PALB2 variants and may improve the yield of genetic diagnoses in this field.<\/jats:p>","DOI":"10.3390\/ijms23020667","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T20:29:26Z","timestamp":1641760166000},"page":"667","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification and Characterization of an Exonic Duplication in PALB2 in a Man with Synchronous Breast and Prostate Cancer"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0243-8295","authenticated-orcid":false,"given":"Ahmed","family":"Bouras","sequence":"first","affiliation":[{"name":"Genetic and Cancer Medical Laboratory HCL-CLB, Hospices Civils de Lyon, 69008 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Lafaye","sequence":"additional","affiliation":[{"name":"Genetic and Cancer Medical Laboratory HCL-CLB, Hospices Civils de Lyon, 69008 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Leone","sequence":"additional","affiliation":[{"name":"Genetic and Cancer Medical Laboratory HCL-CLB, Hospices Civils de Lyon, 69008 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0351-6689","authenticated-orcid":false,"given":"Zine-Eddine","family":"Kherraf","sequence":"additional","affiliation":[{"name":"Institute for Advanced Biosciences, University Grenoble Alpes, INSERM, CNRS, 38000 Grenoble, France"},{"name":"UM GI-DPI, University Hospital Grenoble Alpes, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanguy","family":"Martin-Denavit","sequence":"additional","affiliation":[{"name":"Genetics Departement, Hospices Civils de Lyon, 69500 Bron, France"},{"name":"Center for Medical Genetics, Alpig\u00e8ne, 69007 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Fert-Ferrer","sequence":"additional","affiliation":[{"name":"Centre Hospitalier M\u00e9tropole Savoie, Genetics Departement, 73011 Chambery, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Calender","sequence":"additional","affiliation":[{"name":"Genetic and Cancer Medical Laboratory HCL-CLB, Hospices Civils de Lyon, 69008 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Boutry-Kryza","sequence":"additional","affiliation":[{"name":"Genetic and Cancer Medical Laboratory HCL-CLB, Hospices Civils de Lyon, 69008 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast Cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2013.2541","article-title":"Hereditary Breast and Ovarian Cancer Susceptibility Genes (Review)","volume":"30","author":"Kobayashi","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bulcan.2018.08.003","article-title":"The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition","volume":"105","author":"Moretta","year":"2018","journal-title":"Bull. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/j.seminoncol.2016.10.001","article-title":"Updates on Breast Cancer Genetics: Clinical Implications of Detecting Syndromes of Inherited Increased Susceptibility to Breast Cancer","volume":"43","author":"Cobain","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Campos, F.A.B., Rouleau, E., Torrezan, G.T., Carraro, D.M., Casali da Rocha, J.C., Mantovani, H.K., da Silva, L.R., de Toledo Os\u00f3rio, C.A.B., Moraes Sanches, S., and Caputo, S.M. (2021). Genetic Landscape of Male Breast Cancer. Cancers, 13.","DOI":"10.3390\/cancers13143535"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1073\/pnas.0811159106","article-title":"PALB2 Is an Integral Component of the BRCA Complex Required for Homologous Recombination Repair","volume":"106","author":"Sy","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic Mutations in PALB2 Cause Fanconi Anemia Subtype FA-N and Predispose to Childhood Cancer","volume":"39","author":"Reid","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng1942","article-title":"Fanconi Anemia Is Associated with a Defect in the BRCA2 Partner PALB2","volume":"39","author":"Xia","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171202","article-title":"Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene","volume":"324","author":"Jones","year":"2009","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-Cancer Risk in Families with Mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/jmedgenet-2016-103839","article-title":"PALB2, CHEK2 and ATM Rare Variants and Cancer Risk: Data from COGS","volume":"53","author":"Southey","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-5751-8-12","article-title":"PALB2 Variants in Hereditary and Unselected Finnish Prostate Cancer Cases","volume":"8","author":"Pakkanen","year":"2009","journal-title":"J. Negat. Results Biomed."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng.2560","article-title":"Identification of 23 New Prostate Cancer Susceptibility Loci Using the ICOGS Custom Genotyping Array","volume":"45","author":"Eeles","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families","volume":"38","author":"Yang","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41416-021-01410-0","article-title":"PALB2 Mutations and Prostate Cancer Risk and Survival","volume":"125","author":"Stempa","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","article-title":"A Recurrent Mutation in PALB2 in Finnish Cancer Families","volume":"446","author":"Erkko","year":"2007","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer","volume":"373","author":"Mateo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"a003657","DOI":"10.1101\/mcs.a003657","article-title":"Response to Olaparib in a PALB2 Germline Mutated Prostate Cancer and Genetic Events Associated with Resistance","volume":"5","author":"Horak","year":"2019","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA Repair Defect in BRCA Mutant Cells as a Therapeutic Strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.6004\/jnccn.2021.0008","article-title":"NCCN Guidelines Insights: Prostate Cancer, Version 1.2021","volume":"19","author":"Schaeffer","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Seong, M.-W., Cho, S.I., Kim, K.H., Chung, I.Y., Kang, E., Lee, J.W., Park, S.K., Lee, M.H., Choi, D.H., and Yom, C.K. (2014). A Multi-Institutional Study of the Prevalence of BRCA1 and BRCA2 Large Genomic Rearrangements in Familial Breast Cancer Patients. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-645"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1158\/1055-9965.EPI-13-0745-T","article-title":"The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer","volume":"22","author":"Janatova","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-016-4021-7","article-title":"Characterization of a Novel Germline PALB2 Duplication in a Hereditary Breast and Ovarian Cancer Family","volume":"160","author":"Yang","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41436-018-0092-7","article-title":"DNA Breakpoint Assay Reveals a Majority of Gross Duplications Occur in Tandem Reducing VUS Classifications in Breast Cancer Predisposition Genes","volume":"21","author":"Richardson","year":"2019","journal-title":"Genet. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41436-021-01151-8","article-title":"Management of Individuals with Germline Variants in PALB2: A Clinical Practice Resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Tischkowitz","year":"2021","journal-title":"Genet. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Parenti, S., Rabacchi, C., Marino, M., Tenedini, E., Artuso, L., Castellano, S., Carretta, C., Mallia, S., Cortesi, L., and Toss, A. (2021). Characterization of New ATM Deletion Associated with Hereditary Breast Cancer. Genes, 12.","DOI":"10.3390\/genes12020136"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/humu.22101","article-title":"Guidelines for Splicing Analysis in Molecular Diagnosis Derived from a Set of 327 Combined in Silico\/in Vitro Studies on BRCA1 and BRCA2 Variants","volume":"33","author":"Houdayer","year":"2012","journal-title":"Hum. Mutat."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/2\/667\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:27:01Z","timestamp":1760362021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/2\/667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23020667"],"URL":"https:\/\/doi.org\/10.3390\/ijms23020667","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]}}}